Ampio Pharma (AMPE) Founder, CEO Extend Lock-Up Agreements

July 3, 2012 7:13 AM EDT Send to a Friend
Get Alerts AMPE Hot Sheet
Trade AMPE Now!
Join SI Premium – FREE
Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), reports that Dr. David Bar-Or, Ampio's Founder, Chief Scientific Officer and largest shareholder, and Michael Macaluso, Ampio's CEO, Chairman and Lead Investor, have extended their July 15th 2012 lock-up agreement until January of 2013. This extended lockup encompasses more than two-thirds of the company's shares owned by executives, management and directors.


Serious News for Serious Traders! Try StreetInsider.com Premium Free!

You May Also Be Interested In





Related Categories

Insiders' Blog

Add Your Comment